Skip to content

Phase Contrast Imaging used for a quantitative evaluation of myocardial contractility in left ventricular dilatation and for the detection of myocardial ischemia

Phase Contrast Imaging used for a quantitative evaluation of myocardial contractility in left ventricular dilatation and for the detection of myocardial ischemia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00000015
Enrollment
100
Registered
2008-09-05
Start date
2005-02-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the circulation system I20-I25

Interventions

Group 1: Evaluation of myocardial velocities in patients with LVEDD>55 mm: Patients with dilatative cardiomyopathy Group 2: Evaluation of myocardial velocities in patients with LVEDD>55 mm: Patients w

Sponsors

Universitätsklinikum Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Part 1: Patients with LVEDD>55 mm: 20 patients with dilatative cardiomyopathy 20 patients with relevant mitral- oder aortic insufficiency 20 patients with arterial hypertension or aortic stenosis Part 2: 20 patients with suspected CAD Part 3: 20 patients with acute myocardial infarction Amendment: 1. 60 additional healthy volunteers 2. 20 patients with complete left bundle branch block without cardiac disease and normal LVEF 3. 50 patients mit with complete left bundle branch block, LVEF=35%, LVEDD > 55 mm and heart failure (NYHA class = II) with dilated cardiomyopathy before CRT 4. 80 patients after heart transplantation (also follow-up)

Exclusion criteria

Exclusion criteria: Part 1: CAD, contraindications against MRI Part 2: Contraindications against MRI, Gadolinium or Adenosin. Reduced left ventricular function, relevant valvular disease, left bundle branch block. Part 3: Contraindications against MRI, Gadolinium or Adenosin. Reduced left ventricular function, relevant valvular disease, left bundle branch block.

Design outcomes

Primary

MeasureTime frame
Differences/changes of myocardial motion

Secondary

MeasureTime frame
in patients after HTX or CRT: changes of clinical parameters (NYHA classes etc.)

Countries

Germany

Contacts

Public ContactDaniela Föll

Kardiologie und Angiologie I, Universitäts Herzzentrum freiburg

daniela.foell@uniklinik-freiburg.de+49 761 270 34010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026